Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE(−/−) mice

BACKGROUND AND AIMS: Our previous in vitro and clinical work has demonstrated anti-inflammatory effects of berberine (BBR), but the clinical application of BBR is limited by its poor bioavailability. Derivatives of BBR have been suggested to have enhanced bioavailability compared to BBR. In this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Junwen, Cao, Jiatian, Fang, Lu, Liu, Bo, Zhou, Qing, Sun, Yinggang, Wang, Yue, Li, Yigang, Meng, Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261588/
https://www.ncbi.nlm.nih.gov/pubmed/25425200
http://dx.doi.org/10.1186/s12967-014-0326-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261588/
https://www.ncbi.nlm.nih.gov/pubmed/25425200
http://dx.doi.org/10.1186/s12967-014-0326-7

Ejemplares similares